Trial Profile
Phase I single and multiple ascending dose study of the vasopressin-1 receptor antagonist RG 7314
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 09 Nov 2011
Price :
$35
*
At a glance
- Drugs Balovaptan (Primary)
- Indications Autistic disorder
- Focus Adverse reactions
- 09 Nov 2011 New trial record